[HTML][HTML] Genetic determinants for chemo-and radiotherapy resistance in bladder cancer

A Mari, D D'Andrea, M Abufaraj, B Foerster… - Translational …, 2017 - ncbi.nlm.nih.gov
Bladder cancer (BCa) is burdened by high rates of chemo-and radio-resistance. We
reviewed and summarized the current evidence regarding the genetic determinants of …

Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer

C Perez-Ramirez, M Canadas-Garre, A Alnatsha… - Surgical Oncology, 2017 - Elsevier
Background Surgery is the standard treatment for early-stage NSCLC, and platinum-based
chemotherapy remains as the treatment of choice for advanced-stage NSCLC patients with …

Influência dos polimorfismos genéticos em doentes com cancro do pulmão submetidos a quimioterapia com fármacos de platina: papel de genes de reparação do …

SCC Mendes - 2017 - search.proquest.com
A quimioterapia com fármacos de platina é a primeira linha de tratamento para a maior
parte dos doentes com cancro do pulmão. Os fármacos de platina atuam formando ligações …